Skip to main content
Powered by
buzzwords.news
(
US Patent 11,232,363 B2
) · created by
d-e-v.com
buzzwords.technology
main_menu
Home
Channels
Personalize
Headlines
Alexa Skill
Search
Search
Home
Headlines
United Therapeutics Wins Patent Case Against Liquidia
posted:
Wed, 09/30/2026 - 23:17 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Viking Therapeutics Stock Soars 36% on Weight-Loss Drug Data. Why It's Not Too Late to Buy the Stock.
posted:
Wed, 09/30/2026 - 17:20 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Larimar Therapeutics Names John Harlow As President And COO
posted:
Wed, 09/30/2026 - 01:11 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Eli Lilly Stock Barely Moved Following Viking Therapeutics' Impressive Clinical Results. Here's Why.
posted:
Tue, 09/29/2026 - 17:50 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Unicycive Therapeutics Resubmits Oxylanthanum Carbonate NDA To FDA
posted:
Tue, 09/29/2026 - 09:04 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Kyowa Kirin, Knight Therapeutics Enter Distribution Deal For POTELIGEO In Latin America
posted:
Tue, 09/29/2026 - 09:02 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Decoy Therapeutics Reports Preclinical Data For Weekly Intranasal DCOY-CoV
posted:
Tue, 09/29/2026 - 08:15 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
CRISPR Therapeutics Has 2 Key Catalysts Coming by the End of 2026. Is the Market Underestimating Them?
posted:
Tue, 09/29/2026 - 05:12 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Egetis Therapeutics' EMCITATE Wins FDA Approval For MCT8 Deficiency
posted:
Tue, 09/29/2026 - 01:38 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Summit Therapeutics Jumps on $2 Billion AstraZeneca Deal
posted:
Mon, 09/28/2026 - 17:42 EDT
by:
Bloomberg Daybreak
#channels::
#All
,
#Business
,
#Bloomberg
,
#BloombergDaybreak
,
#Stocks
August 2027 Options Now Available For Halozyme Therapeutics (HALO)
posted:
Mon, 09/28/2026 - 10:56 EDT
by:
Nasdaq Options
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#Options
,
#StockOptions
,
#NasdaqOptions
Merck Signs $2.13 Bln License Deal With SciBrunch Therapeutics For KRAS G12D Inhibitor
posted:
Mon, 09/28/2026 - 08:02 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Addex Therapeutics H1 Net Loss Widens, Operating Loss Narrows; Advances GABAB PAM Cough Program
posted:
Mon, 09/28/2026 - 04:44 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Why Summit Therapeutics Stock Is Sinking Today
posted:
Tue, 05/28/2024 - 12:13 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Sarepta Therapeutics Enters Oversold Territory (SRPT)
posted:
Tue, 05/28/2024 - 11:58 EDT
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Pagination
Previous page
‹‹
Page 2
Next page
››